Quick Answer
Aptevo Therapeutics Inc. reported Total Assets of $27.19 million for fiscal year 2025.
Aptevo Therapeutics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $27.19M | +74.4% |
| 2024 | $15.59M | -37.2% |
| 2023 | $24.84M | -27.4% |
| 2022 | $34.22M | -39.6% |
| 2021 | $56.60M | +5.7% |
| 2020 | $53.55M | +0.3% |
| 2019 | $53.41M | -20.9% |
| 2018 | $67.49M | -42.3% |
| 2017 | $117.01M | +27.4% |
| 2016 | $91.86M | -31.2% |
| 2016 | $133.47M | +4.3% |
| 2016 | $127.92M | +0.1% |
| 2015 | $127.77M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $27.00M | +78.2% | +72.8% |
| June 30, 2025 | $15.62M | +4.7% | +87.3% |
| March 31, 2025 | $8.34M | -52.7% | -46.5% |
| December 31, 2024 | $15.59M | -37.2% | +2.9% |
| September 30, 2024 | $15.15M | -44.2% | +1.5% |
| June 30, 2024 | $14.92M | -48.4% | -15.4% |
| March 31, 2024 | $17.63M | -49.6% | -29.0% |
| December 31, 2023 | $24.84M | -27.4% | -8.4% |
- Aptevo Therapeutics Inc. showed an increase of +74.4% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Aptevo Therapeutics Inc.’s total assets has declined by 78.7% (from $127.77 million to $27.19 million).
- The most recent figure is from Aptevo Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: